Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?
In its severest forms, decompression sickness (DCS) may extend systemically and/or induce severe neurological deficits, including paralysis or even death. It seems that the sterile and ischemic inflammatory phenomena are consecutive to the reaction of the bubbles with the organism and that the blood...
Main Authors: | Kate Lambrechts, Sébastien de Maistre, Jacques H. Abraini, Jean-Eric Blatteau, Jean-Jacques Risso, Nicolas Vallée |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2018.00906/full |
Similar Items
-
Fluoxetine protection in decompression sickness in mice is enhanced by blocking TREK-1 potassium channel with the spadin antidepressant.
by: Nicolas eVallée, et al.
Published: (2016-02-01) -
Thirty-five Day Fluoxetine Treatment Limits Sensory-Motor Deficit and Biochemical Disorders in a Rat Model of Decompression Sickness
by: Caroline Cosnard, et al.
Published: (2017-09-01) -
Reduction in the Level of Plasma Mitochondrial DNA in Human Diving, Followed by an Increase in the Event of an Accident
by: Jean-Eric Blatteau, et al.
Published: (2018-11-01) -
Protective effects of fluoxetine on decompression sickness in mice.
by: Jean-Eric Blatteau, et al.
Published: (2012-01-01) -
Demonstration by Infra-Red Imaging of a Temperature Control Defect in a Decompression Sickness Model Testing Minocycline
by: Anne-Virginie Desruelle, et al.
Published: (2019-07-01)